Article
p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case-cohorts within a Japanese prospective study.
Cancer science - 1 Dec 2022
Nakano Shiori, Yamaji Taiki, Katagiri Ryoko, Sawada Norie, Inoue Manami, Tsugane Shoichiro, Iwasaki Motoki
Abstract excerpt
The tumor suppressor protein, p53, is a critical molecule involved in cancer development. However, the association between p53 Arg72Pro polymorphism and cancer risk remains unclear, possibly due to the pro-tumor potential of p53 under metabolic stress. Here, we hypothesized that the p53 Arg72Pro polymorphism plays different roles during tumorigenesis by adiposity status. We measured baseline body mass index (BMI)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
